Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Lifeward Ltd. - Ordinary Shares
(NQ:
LFWD
)
6.000
-0.060 (-0.99%)
Delayed Quote
Updated: 3:59 PM EDT, Oct 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Lifeward Ltd. - Ordinary Shares
< Previous
1
2
3
Next >
Lifeward’s ReWalk® Personal Exoskeleton Demonstrates Sustained Long-Term Home Use and Patient Satisfaction in Latest Independent Peer-Reviewed Study
October 14, 2026
From
Lifeward Ltd.
Via
GlobeNewswire
Peer-Reviewed Study of Lifeward’s ReWalk® Exoskeleton Reports Significant Improvements in Daily Activity Performance, Satisfaction, and Pain
September 15, 2026
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward Publishes Updated Investor Presentation Highlighting Commercial Growth Strategy
September 08, 2026
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward Appoints Josh Hexter Interim Chief Executive Officer and Rami Aviram Chief Financial Officer
August 31, 2026
Experienced leadership team to build on established commercial platform and accelerate Lifeward’s next phase of growth with continuity of strategy
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward Reports Strong Second Quarter 2026 Financial Results as Commercial Execution Drives Growth
August 14, 2026
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward to Report Second Quarter 2026 Financial Results on August 14, 2026
August 07, 2026
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward Launches Pilot Program with Ottobock Care to Expand National Access to ReWalk® Personal Exoskeleton
August 05, 2026
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic Financing
July 07, 2026
Initial $5.6 million provides immediate capital to accelerate commercialization of Lifeward's restorative healthcare platform; additional $5.6 million available upon achievement of defined commercial...
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed Platform
May 19, 2026
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward Reports First Quarter 2026 Financial Results
May 15, 2026
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward to Report First Quarter 2026 Financial Results on May 15, 2026
May 11, 2026
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward Announces New ReWalk® Data Presented at ASIA 2026 Conference Demonstrating a Comprehensive Longitudinal Safety Analysis for a Powered Exoskeleton
May 04, 2026
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward Successfully Closes on Strategic Partnership with Oramed
March 25, 2026
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward Reports Fourth Quarter and Full Year 2025 Financial Results
March 18, 2026
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical Company
March 13, 2026
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward Regains Compliance with Nasdaq Minimum Bid Price Requirement
March 11, 2026
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026
March 10, 2026
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward Announces Collaboration With Shirley Ryan AbilityLab to Expand Access for the ReWalk Personal Exoskeleton
March 02, 2026
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward to Acquire Powered Upper Body Exoskeleton with AI Capabilities Designed to Restore Function to Stroke Survivors
February 25, 2026
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward Announces Reverse Share Split
February 20, 2026
Reverse split initiated as Lifeward enters strategic partnership agreement and repositions as MedTech innovation company
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward’s ReWalk™ Personal Exoskeleton Now Covered by Aetna, Coverage Expands to Include Three of the Largest Medicare Advantage Insurers
February 17, 2026
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company
January 13, 2026
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward Appoints Bob Marshall as Chairman of the Board
December 19, 2025
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward Expands International Distribution of its ReWalk® Personal Robotic Exoskeleton into Mexico, Thailand, and the United Arab Emirates
December 17, 2025
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward Broadens Reimbursement Coverage for ReWalk 7 Personal Robotic Exoskeleton as Humana Medicare Advantage Plan Issues Prior Authorization Approval
December 03, 2025
From
Lifeward Ltd.
Via
GlobeNewswire
UnitedHealthcare Medicare Advantage Plan Issues Prior Authorization Approval for a ReWalk 7 Personal Exoskeleton
November 17, 2025
Approval marks continued progress in expanding reimbursement pathways and accelerating access to advanced personal exoskeleton technology for individuals with spinal cord injury.
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward Ltd. Reports Third Quarter 2025 Financial Results
November 14, 2025
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward to Report Third Quarter Financial Results on November 14, 2025
November 10, 2025
From
Lifeward Ltd.
Via
GlobeNewswire
First Commercial Medicare Advantage Plan Provides Payment for ReWalk 7 Personal Exoskeleton
September 09, 2025
From
Lifeward Ltd.
Via
GlobeNewswire
Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskeleton
September 08, 2025
Seventh generation of industry-leading ReWalk Exoskeleton is now cleared for commercial launch in the European Union
From
Lifeward Ltd.
Via
GlobeNewswire
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1
